By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Chronogen Inc. 

1205, Avenue Docteur Penfield

Montreal    H3A 1B1  Canada
Phone: 514-398-6400 Fax: 514-398-1674



Company News
Tripos (TRPS) Announces Advancement To Pre-Clinical Development In Drug Discovery Collaboration With Chronogen Inc. 6/28/2006 5:00:38 PM
Chronogen Inc. Receives Approval To Proceed With A Phase I/II Clinical Trial 4/26/2006 10:18:16 AM
Chronogen Inc. Secures (US) $3.275M Of Financing From MMV Financial Inc. 3/28/2006 11:08:28 AM
Chronogen Inc. Strengthens R & D With A New Management Position 1/9/2006 12:43:47 PM
Chronogen Inc. Demonstrates That Mammalian Aging Is Under The Control Of CLK-1 Activity 10/26/2005 11:51:26 AM
Chronogen Inc. Announces Two Senior Appointments10/19/2005 5:13:15 PM
Chronogen Inc. Announces A Partnership With Sosei Co., Ltd. For The Screening Of The Sosei Drug Reprofiling Platform(R) Compound Library10/19/2005 5:12:12 PM
Chronogen Inc. Names Dr. Max Fehlmann, Ph.D. MBA, New President And CEO10/19/2005 5:12:03 PM
Chronogen Inc. Appoints New Scientific Advisory Board10/19/2005 5:11:39 PM
Chronogen Inc. Names Mr. Kees Been, Chief Executive Officer Of Bionaut Pharmaceuticals, Inc. To Board Of Directors10/19/2005 5:10:57 PM